Carregant...

Palonosetron versus older 5-HT(3) receptor antagonists for nausea prevention in patients receiving chemotherapy: a multistudy analysis

BACKGROUND: No clinical standard currently exists for the optimal management of nausea induced by emetogenic chemotherapy, particularly delayed nausea. OBJECTIVE: To compare the efficacy and safety of palonosetron with older 5-HT(3) receptor antagonists (RAs) in preventing chemotherapy-induced nause...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Community Support Oncol
Autors principals: Morrow, Gary R, Schwartzberg, Lee, Barbour, Sally Y, Ballinari, Gianluca, Thorn, Michael D, Cox, David
Format: Artigo
Idioma:Inglês
Publicat: 2014
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4734136/
https://ncbi.nlm.nih.gov/pubmed/25830233
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!